Clinical Trial Update: A Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-erosive Gastroesophageal Reflux Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing the efficacy and safety of E3810 in patients with non-erosive gastroesophageal reflux disease has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-erosive Gastroesophageal Reflux Disease

Drugs mentioned

• E3810

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Non-erosive Gastroesophageal Reflux Disease | Phase 3 | Status: COMPLETED | Results posted: 2011-06-17